BK and CaV1.3 channels interact early during biogenesis, assembling intracellularly before membrane localization, indicating ...

Stocks that are trending today. Stéphane Bancel, CEO of Moderna , said: "We remain focused on our strategy to build a large ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

Benefits seen from embracing platform technologies, combined with the role such systems played during the pandemic, are key dynamics.

An alternative splicing regulator previously implicated in calcium signaling in the heart ensures cell-type-specific mRNA processing of long neuronal mRNAs in the mouse brain.

The Commerce Department is floating a proposal that would impede the commercialization of university researchers’ most ...

Last week, biotechnology company Ascidian Therapeutics announced a manufacturing partnership with gene-therapy–focused ...

Researchers developed a single-cell sequencing method that simultaneously measures cancer-linked DNA mutations and gene ...

The complaint alleges that Moderna used the patented fluorescent protein technology without permission during preclinical ...

Jefferies analysts forecast a $1 billion market opportunity for each of Sarepta’s siRNA programs for facioscapulohumeral muscular dystrophy and myotonic dystrophy type 1.

Moderna Inc. said its US Covid business did better than expected last year, a rare bright spot for the vaccine maker, which ...

The Independent Medical Alliance (IMA) today announced the release of Volume 2, Issue 1 of the Journal of Independent Medicine—the journal's fifth issue to date and the first issue of its second year ...